Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text Free
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cardiff, R. D.
Right arrow Articles by Ward, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cardiff, R. D.
Right arrow Articles by Ward, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Precancer in Mice: Animal Models Used to Understand, Prevent, and Treat Human Precancers

Robert D. Cardiff1
Miriam R. Anver2
Gregory P. Boivin3
Marcus W. Bosenberg4
Robert R. Maronpot5
Alfredo A. Molinolo6
Alexander Yu Nikitin7
Jerold E. Rehg8
George V. Thomas9
Robert G. Russell10
Jerrold M. Ward11

1 The UCD Center for Comparative Medicine, University of California, Davis, Davis, California 95616, USA
2 Pathology/Histotechnology Laboratory, SAIC Frederick, Inc./NCI-Frederick, Frederick, Maryland 21702, USA
3 Veterans Affairs Medical Center and University of Cincinnati, Department of Pathology and Laboratory Medicine, Cincinnati, Ohio 45220, USA
4 Department of Pathology, University of Vermont, Burlington, Vermont 05405, USA
5 Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709, USA
6 Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892, USA
7 Department of Biomedical Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York 14853, USA
8 Pathology Department, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA
9 Department of Pathology, UCLA, Los Angeles, California 90095, USA
10 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, Distric of Columbia 20057, USA
11 Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, NIH, and SoBran, Inc., Bethesda, Maryland 20892-8135, USA

Correspondence: Address correspondence to: Robert D. Cardiff, Center for Comparative Medicine, Hutchison Drive and CR 98, University of Califonia, Davis, Davis, CA 95616, USA. e-mail:rdcardif{at}ucdavis.edu

We present a status report from the NCI Mouse Models of Human Cancers Consortium (MMHCC) Precancers Workshop held November 8 and 9, 2004. An expert panel, the Mouse Models Group (MMG) evaluated the status of mouse models of precancer emphasizing genetically engineered mouse models, especially of lining epithelium and their utilitarian value to human carcinogenesis. An outline of the background for the panel’s considerations is provided with examples of past and current precancerous lesions in mice. The experimental use of oncogenic viruses and chemical carcinogens in mice led to operational definitions of initiation, promotion, and preneoplasia Preneoplastic and precancerous lesions are found in these models. In this precancer concept, most preneoplastic lesions are considered as potentially precancerous or at least an earlier stage in cancer development than typical pre-invasive epithelial lesions, which are often seen in these mouse models. Genetically engineered mice, used to test the oncogenicity of individual genes, develop precancers that are initiated by defined molecular and histopathologic changes. The mouse can be used to isolate and study precancers in detail, thereby providing a level of biological understanding not readily available in clinical disease. These studies suggest that genetically engineered mice are very useful preclinical models for chemoprevention and therapy.

Key Words: Precancer • mouse • models • GEM (Genetic Engineered Mice) • pathology • preclinical • trials

Abbreviations: ACF, aberrant crypt foci • BCAC, B-catenin-accumulated crypts • DMBA, 7, 12-dimethylbenz(a)anthracene • GEM, genetically engineered mouse • HAN, hyperplastic alveolar nodule • mGIN, mouse gastrointestinal neoplasia • MMG, Mouse Models Group • MMHCC, Mouse Models of Human Cancers Consortium • mMIN, mouse mammary intraepithelial neoplasia • MMTV, mouse mammary tumor virus • mPIN, murine prostatic intraepithelial neoplasia • mSkIN, mouse skin intraepithelial neoplasia • SENCAR, sensitivity to carcinogens • TPA, 12-O-tetradecanoyl-phorbol-13-acetate

Toxicologic Pathology, Vol. 34, No. 6, 699-707 (2006)
DOI: 10.1080/01926230600930129


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?